Compound 1 decreased the ΔΨm level of HepG-2 cells. by Jing Zhang (23775)

Dex decreases dispersal of GBM cells. by Stephen Shannon (784424)

Subjects:

The concentration-dependent decrease of intracellular D-Ser concentrations produced by incubation of PC-12 cells with the enantiomers of ketamine (Ket) and its major metabolites expressed as IC₅₀ values and percent (%) maximum decrease from vehicle-treated PC-12 cells. by Nagendra S. Singh (2620399)

TMD residues decrease sensitivity. by Ákos Nemecz (356830)

“…Glu residues are color coded based upon effect, with residues in red producing a significant decrease in pH₅₀, and in yellow, an insignificant or weak effect, whereas the dark purple and magenta for His residues are synonymous to the red of Glu residues. …”

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes. by Fangrui Ding (659863)

“…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of <i>dom</i> decreased <i>per</i> and <i>tim</i> mRNA levels (middle and right panels), while <i>clk</i> was normal (left panel). …”

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…Error bars indicated SEM. CHPG, α-amino-2-chloro-5-hydroxybenzeneacetic acid; DHPG, (S)-3,5-Dihydroxyphenylglycine; GABA_A receptor, γ-Aminobutyric acid type A receptor; GDP-β-S, Guanosine 5ʹ-O-(2-Thiodiphosphate); GlyR, glycine receptor; IPSC, inhibitory postsynaptic current; mGluR5, metabotropic glutamate receptor 5; MPEP, 6-Methyl-2-(phenylethynyl) pyridine; PD98059, 2ʹ-Amino-3ʹ-methoxyflavone; Ro-32-0432, 2-{8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-3-yl}-3-(1-methyl-1H-indol-3-yl)maleimide.…”

IQG-607 decreases the infection of macrophages by <i>L</i>. <i>braziliensis</i> amastigotes. by Camila F. Amorim (676792)

TTLL12 knockdown in HEp-2 and DU145 cells decreases cell survival in the presence of nitrotyrosine. by Amit Deshpande (255211)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…<p>(<b>A</b>) Genome-wide expression of 5′ splice sites, 3′ splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 µM, 18 hours), based on total RNA-Seq (dUTP method <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone.0089673-Parkhomchuk1" target="_blank">[18]</a>, Illumina). …”

Purified apolipoproteins decrease endothelial exocytosis. by Scott J. Cameron (838315)

P2Y₁₂ deficiency or inhibition decreases NFκB expression. by Corey M. Webster (442040)

“…<p>Numbers of cells positive for NF<b>κ</b>B’s p65 subunit were decreased among P2Y₁₂^+/− and treated mice (A, C). …”

Baseline characteristics of women by randomization method^$ (mITT analysis). by Chanel Avenant (409756)

Subjects:

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”